🇺🇸 FDA
Patent

US 9649339

LAT adapter molecule for enhanced T-cell signaling and method of use

granted A61KA61K2239/55A61K2239/57

Quick answer

US patent 9649339 (LAT adapter molecule for enhanced T-cell signaling and method of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2239/55, A61K2239/57, A61K38/00, A61K40/11